Suppr超能文献

炭疽芽孢杆菌生物变种炭疽杆菌产生的毒素和荚膜会影响其在巨噬细胞和动物模型中的致病性。

Toxin and capsule production by Bacillus cereus biovar anthracis influence pathogenicity in macrophages and animal models.

作者信息

Jiranantasak Treenate, Bluhm Andrew P, Chabot Donald J, Friedlander Arthur, Bowen Richard, McMillan Ian A, Hadfield Ted L, Hartwig Airn, Blackburn Jason K, Norris Michael H

机构信息

Spatial Epidemiology & Ecology Research Laboratory, Department of Geography, University of Florida, Gainesville, Florida, United States of America.

Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.

出版信息

PLoS Negl Trop Dis. 2024 Dec 23;18(12):e0012779. doi: 10.1371/journal.pntd.0012779. eCollection 2024 Dec.

Abstract

Bacillus cereus biovar anthracis (Bcbva) causes anthrax-like disease in animals, particularly in the non-human primates and great apes of West and Central Africa. Genomic analyses revealed Bcbva as a member of the B. cereus species that carries two plasmids, pBCXO1 and pBCXO2, which have high sequence homology to the B. anthracis toxin and polyglutamate capsule encoding plasmids pXO1 and pXO2, respectively. To date, only a few studies have investigated the effect of variations in Bcbva sporulation, toxin, and capsule synthesis on animal and macrophage pathogenicity compared to B. anthracis, therefore more research is needed to gain a better understanding of the pathogenesis of this emerging infection. Here, we report that Bcbva can multiply and vegetatively survive on nutrient-rich media for a minimum of six days while generating spores. Sporulation of Bcbva occurred faster and more extensively than B. anthracis Ames. Bcbva tended to secrete less protective antigen (PA) than B. anthracis Ames when cultured in growth medium. We found Bcbva produced a substantially higher amount of attached poly-ƴ-D-glutamic acid (PDGA) capsule than B. anthracis Ames when grown in medium supplemented with human serum and CO2. In a phagocytosis assay, Bcbva spores showed reduced internalization by mouse macrophages compared to B. anthracis Ames. Our research demonstrated that Bcbva is more virulent than B. anthracis Ames using two in vivo models, Galleria mellonella larvae and guinea pigs. Following that, the efficacy of the veterinary vaccine Sterne strain 34F2 against anthrax-like disease was assessed in guinea pigs. Sterne vaccinated guinea pigs had significantly increased anti-PA titers compared to the unvaccinated control group. Toxin neutralizing antibody titers in vaccinated guinea pigs correlated with anti-PA titers. This indicates the Sterne vaccine provides adequate protection against Bcbva infection in laboratory animals.

摘要

蜡样芽孢杆菌炭疽生物变种(Bcbva)可在动物身上引发类似炭疽的疾病,尤其是在西非和中非的非人灵长类动物和大猩猩中。基因组分析显示,Bcbva是蜡样芽孢杆菌属的成员,携带两个质粒,即pBCXO1和pBCXO2,它们分别与炭疽芽孢杆菌的毒素编码质粒pXO1和聚谷氨酸荚膜编码质粒pXO2具有高度序列同源性。迄今为止,与炭疽芽孢杆菌相比,只有少数研究调查了Bcbva芽孢形成、毒素和荚膜合成变异对动物和巨噬细胞致病性的影响,因此需要更多研究来更好地了解这种新出现感染的发病机制。在此,我们报告Bcbva可在营养丰富的培养基上繁殖并以营养体形式存活至少六天,同时产生孢子。Bcbva的芽孢形成比炭疽芽孢杆菌埃姆斯株更快且更广泛。在生长培养基中培养时,Bcbva分泌的保护性抗原(PA)往往比炭疽芽孢杆菌埃姆斯株少。我们发现,当在添加人血清和二氧化碳的培养基中生长时,Bcbva产生的附着型聚-γ-D-谷氨酸(PDGA)荚膜比炭疽芽孢杆菌埃姆斯株多得多。在吞噬试验中,与炭疽芽孢杆菌埃姆斯株相比,Bcbva孢子被小鼠巨噬细胞内化的程度降低。我们的研究使用两种体内模型,即大蜡螟幼虫和豚鼠,证明Bcbva比炭疽芽孢杆菌埃姆斯株的毒性更强。在此之后,在豚鼠中评估了兽用疫苗斯特恩株34F2对类似炭疽疾病的疗效。与未接种疫苗的对照组相比,接种斯特恩疫苗的豚鼠抗PA滴度显著提高。接种疫苗的豚鼠体内毒素中和抗体滴度与抗PA滴度相关。这表明斯特恩疫苗能为实验动物提供针对Bcbva感染的充分保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc2/11706511/5d87f59095e2/pntd.0012779.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验